IDPH--Positive preliminary results for pivotal trial of ID Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bob L who wrote (1571)	6/3/1998 11:25:00 AM
From: Roudy	Read Replies (2) of 1762

Rituxan gets European marketing clearance. Full story at this site: biz.yahoo.com I talked with IR at IDEC recently. They know of a couple of institutions that have put selling pressure on the stock thus the recent decline. I thought it was short selling, but the recent short interest numbers didn't show any change from the prior month. Sales are in line as indicated in the above press release. All the fundamentals look good here, but the technicals as far as charts go are poor at best.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next